Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia
Clinical trial NCT00088491 · COMPLETED
Trial details
- NCT number
- NCT00088491
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 1205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.